Oxford Nanopore Technologies (LON:ONT) Trading Down 3.7% – Time to Sell?

Posted by Brenda Bartman on Jul 10th, 2026

Shares of Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) traded down 3.7% during trading on Wednesday . The stock traded as low as GBX 111.90 and last traded at GBX 115.60. 58,115,211 shares changed hands during mid-day trading, an increase of 386% from the average session volume of 11,970,034 shares. The stock had previously closed at GBX 120.10.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ONT shares. Citigroup lowered shares of Oxford Nanopore Technologies to a “buy” rating in a report on Friday. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of GBX 218.60.

Read Our Latest Research Report on ONT

Oxford Nanopore Technologies Trading Up 1.2%

The company has a market cap of £1.17 billion, a P/E ratio of -7.97 and a beta of 0.92. The firm’s 50-day moving average price is GBX 123.34 and its 200-day moving average price is GBX 128.12. The company has a quick ratio of 6.01, a current ratio of 3.56 and a debt-to-equity ratio of 8.96.

Insider Activity at Oxford Nanopore Technologies

In other news, insider Nick Keher sold 22,993 shares of the firm’s stock in a transaction that occurred on Tuesday, April 14th. The shares were sold at an average price of GBX 108, for a total value of £24,832.44. Insiders have purchased 22,799 shares of company stock valued at $2,578,133 in the last three months. 2.54% of the stock is currently owned by company insiders.

Oxford Nanopore Technologies Company Profile

(Get Free Report)

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.